NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
21/05/2024
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
GENESIS VECTOR MANUFACTURING SOLUTIONS
ST13
US500000097705178Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Fundamento do pedido
Primeiro uso
Primeiro uso no comércio
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
Joshua M. Gerben, Esq. GERBEN PERROTT, PLLC
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 40
Manufacturing services for others in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals, plasmid DNA production; manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; manufacturing process consulting
Classe 42
Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; research and development of new products for others; process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; quality control for others; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; material testing; product quality testing; scientific laboratory services; scientific research; research and development in the field of gene therapy acceleration, vector genome copy titers, droplet digital polymerase chain reaction (PCR) and digital polymerase chain reaction (PCR), mass spectrometry, capsid characterization, bioassays, plasmid DNA, and analytics testing in the field of genes and gene therapy
Histórico de despachos e eventos da marca no USPTO.
22 publicações encontradas
NOTICE OF REGISTRATION CONFIRMATION EMAILED
21/05/2024
REGISTERED-PRINCIPAL REGISTER
21/05/2024
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
18/04/2024
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
17/04/2024
STATEMENT OF USE PROCESSING COMPLETE
29/02/2024
CASE ASSIGNED TO INTENT TO USE PARALEGAL
29/02/2024
USE AMENDMENT FILED
06/02/2024
TEAS STATEMENT OF USE RECEIVED
06/02/2024
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
26/12/2023
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31/10/2023
PUBLISHED FOR OPPOSITION
31/10/2023
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/10/2023
APPROVED FOR PUB - PRINCIPAL REGISTER
20/09/2023
TEAS/EMAIL CORRESPONDENCE ENTERED
20/09/2023
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/09/2023
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/09/2023
NOTIFICATION OF NON-FINAL ACTION E-MAILED
18/09/2023
NON-FINAL ACTION E-MAILED
18/09/2023
NON-FINAL ACTION WRITTEN
18/09/2023
ASSIGNED TO EXAMINER
09/09/2023
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/12/2022
NEW APPLICATION ENTERED
09/12/2022
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.